A major collaboration aims to expand access to immuno-oncology treatments as FYB206 moves toward FDA submission.
Mumbai, India, 10 December 2025 – Zydus Lifesciences has...
Hospitals, life sciences companies, and insurers turn to agentic AI to ease workloads, speed care, and personalize support.
Agentic AI is rapidly moving from concept...
With mutation-driven therapies and advanced biomarkers shaping the future, AML trials now demand more speed, precision, and operational agility than ever before.
Sheridan, WY, 13...
AI-powered discovery platform EVA™ drives development of a highly selective T-cell engager showing over 90% tumor growth inhibition in pre-clinical studies.
London, 13 November 2025...
Ganaplacide lumefantrine combination delivers cure rates above WHO standards, offering new hope against growing artemisinin resistance.
London, 13 November 2025 – A major step forward...
